BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 33161558)

  • 21. The association of fatigue and social participation in multiple sclerosis as assessed using two different instruments.
    Salter A; Fox RJ; Tyry T; Cutter G; Marrie RA
    Mult Scler Relat Disord; 2019 Jun; 31():165-172. PubMed ID: 31063935
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Health-Related Quality of Life in Patients with CVID Under Different Schedules of Immunoglobulin Administration: Prospective Multicenter Study.
    Pulvirenti F; Cinetto F; Pecoraro A; Carrabba M; Crescenzi L; Neri R; Bonanni L; Fabio G; Agostini C; Spadaro G; Tabolli S; Farrugia A; Quinti I; Milito C
    J Clin Immunol; 2019 Feb; 39(2):159-170. PubMed ID: 30644015
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Assessment of the first presentations of common variable immunodeficiency in a large cohort of patients.
    Esmaeilzadeh H; Jokar-Derisi A; Hassani AH; Yazdani R; Delavari S; Abolhassani H; Mortazavi N; Askarisarvestani A
    BMC Immunol; 2023 Jun; 24(1):9. PubMed ID: 37312036
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gastric Cancer Is the Leading Cause of Death in Italian Adult Patients With Common Variable Immunodeficiency.
    Pulvirenti F; Pecoraro A; Cinetto F; Milito C; Valente M; Santangeli E; Crescenzi L; Rizzo F; Tabolli S; Spadaro G; Agostini C; Quinti I
    Front Immunol; 2018; 9():2546. PubMed ID: 30455695
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Health-Related Quality of Life in Patients with Idiopathic Pulmonary Fibrosis.
    Yount SE; Beaumont JL; Chen SY; Kaiser K; Wortman K; Van Brunt DL; Swigris J; Cella D
    Lung; 2016 Apr; 194(2):227-34. PubMed ID: 26861885
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Current clinical spectrum of common variable immunodeficiency in Spain: The multicentric nationwide GTEM-SEMI-CVID registry.
    Cabañero-Navalon MD; Garcia-Bustos V; Nuñez-Beltran M; Císcar Fernández P; Mateu L; Solanich X; Carrillo-Linares JL; Robles-Marhuenda Á; Puchades-Gimeno F; Pelaez Ballesta A; López-Osle N; Torralba-Cabeza MÁ; Bielsa Masdeu AM; Diego Gil J; Tornador Gaya N; Pascual Castellanos G; Sánchez-Martínez R; Barragán-Casas JM; González-García A; Patier de la Peña JL; López-Wolf D; Mora Rufete A; Canovas Mora A; Forner Giner MJ; Moral Moral P
    Front Immunol; 2022; 13():1033666. PubMed ID: 36389743
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 30-Year Review of Pediatric- and Adult-Onset CVID: Clinical Correlates and Prognostic Indicators.
    Baloh C; Reddy A; Henson M; Prince K; Buckley R; Lugar P
    J Clin Immunol; 2019 Oct; 39(7):678-687. PubMed ID: 31377970
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adapting summary scores for the PROMIS-29 v2.0 for use among older adults with multiple chronic conditions.
    Huang W; Rose AJ; Bayliss E; Baseman L; Butcher E; Garcia RE; Edelen MO
    Qual Life Res; 2019 Jan; 28(1):199-210. PubMed ID: 30209722
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Using PROMIS-29 to predict Neck Disability Index (NDI) scores using a national sample of cervical spine surgery patients.
    Pennings JS; Khan I; Davidson CA; Freitag R; Bydon M; Asher AL; Devin CJ; Archer KR
    Spine J; 2020 Aug; 20(8):1305-1315. PubMed ID: 32413486
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of PROMIS-29® in US Veterans: Diagnostic Concordance and Domain Comparisons with the General Population.
    LaVela SL; Etingen B; Miskevics S; Cella D
    J Gen Intern Med; 2019 Aug; 34(8):1452-1458. PubMed ID: 31144276
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevalence of Granulomas in Patients With Primary Immunodeficiency Disorders, United States: Data From National Health Care Claims and the US Immunodeficiency Network Registry.
    Leung J; Sullivan KE; Perelygina L; Icenogle JP; Fuleihan RL; Lanzieri TM
    J Clin Immunol; 2018 Aug; 38(6):717-726. PubMed ID: 30043271
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Asthma and risk of selective IgA deficiency or common variable immunodeficiency: a population-based case-control study.
    Urm SH; Yun HD; Fenta YA; Yoo KH; Abraham RS; Hagan J; Juhn YJ
    Mayo Clin Proc; 2013 Aug; 88(8):813-21. PubMed ID: 23910409
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CVID-Associated Tumors: Czech Nationwide Study Focused on Epidemiology, Immunology, and Genetic Background in a Cohort of Patients With CVID.
    Kralickova P; Milota T; Litzman J; Malkusova I; Jilek D; Petanova J; Vydlakova J; Zimulova A; Fronkova E; Svaton M; Kanderova V; Bloomfield M; Parackova Z; Klocperk A; Haviger J; Kalina T; Sediva A
    Front Immunol; 2018; 9():3135. PubMed ID: 30723478
    [No Abstract]   [Full Text] [Related]  

  • 34. Complications Associated with Underweight Primary Immunodeficiency Patients: Prevalence and Associations Within the USIDNET Registry.
    Ruffner MA; ; Sullivan KE
    J Clin Immunol; 2018 Apr; 38(3):283-293. PubMed ID: 29619656
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Health-related quality of life in glomerular disease.
    Canetta PA; Troost JP; Mahoney S; Kogon AJ; Carlozzi N; Bartosh SM; Cai Y; Davis TK; Fernandez H; Fornoni A; Gbadegesin RA; Herreshoff E; Mahan JD; Nachman PH; Selewski DT; Sethna CB; Srivastava T; Tuttle KR; Wang CS; Falk RJ; Gharavi AG; Gillespie BW; Greenbaum LA; Holzman LB; Kretzler M; Robinson BM; Smoyer WE; Guay-Woodford LM; Reeve B; Gipson DS;
    Kidney Int; 2019 May; 95(5):1209-1224. PubMed ID: 30898342
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of Bone Mineral Density in Common Variable Immunodeficiency and X-Linked Agammaglobulinaemia Patients.
    Mohebbi A; Azizi G; Tavakolinia N; Abbasi F; Sayarifard F; Karimipour M; Kiaee F; Yazdani R; Ebrahimi SS; Ebrahimi M; Rafiemanesh H; Tafaroji J; Ziaee V; Abolhassani H; Aghamohammadi A
    Endocr Metab Immune Disord Drug Targets; 2017; 17(2):134-140. PubMed ID: 28606051
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Frailty and health-related quality of life in older women with breast cancer.
    Williams GR; Deal AM; Sanoff HK; Nyrop KA; Guerard EJ; Pergolotti M; Shachar SS; Reeve BB; Bensen JT; Choi SK; Muss HB
    Support Care Cancer; 2019 Jul; 27(7):2693-2698. PubMed ID: 30484012
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Modeling primary immunodeficiency disease epidemiology and its treatment to estimate latent therapeutic demand for immunoglobulin.
    Stonebraker JS; Farrugia A; Gathmann B; ; Orange JS
    J Clin Immunol; 2014 Feb; 34(2):233-44. PubMed ID: 24338563
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Health-related quality of life and social determinants of health following COVID-19 infection in a predominantly Latino population.
    Case KR; Wang CP; Hosek MG; Lill SF; Howell AB; Taylor BS; Bridges J; MacCarthy DJ; Winkler P; Tsevat J
    J Patient Rep Outcomes; 2022 Jun; 6(1):72. PubMed ID: 35737279
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Affected health domains in patients with brainstem cavernous malformations.
    Kumar S; Lanzino G; Flemming KD
    Acta Neurochir (Wien); 2019 Dec; 161(12):2521-2526. PubMed ID: 31641860
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.